Physician
Wythe Bland Pediatrics
Wythe Bland Pediatrics was paid $2.84M by Medicaid between Jan 2018 and Jul 2024, across 47 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 68% of everything it billed.
33Billing provider infoWYTHE BLAND PEDIATRICS
WYTHEVILLE, VA 24382
WYTHEVILLE, VA 24382
33aNPI1861734691assigned 03/19/2013
33bProvider typePediatrics Physician
28Total paid$2.84M
24GClaims73,067
24DCodes billed47
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#62 of 817
Median peer was paid$29K
This provider vs. median97×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,221 | $91K | |
| 2019 | 10,736 | $371K | |
| 2020 | 10,210 | $342K | |
| 2021 | 11,719 | $439K | |
| 2022 | 14,026 | $573K | |
| 2023 | 16,277 | $688K | |
| 2024incomplete | 7,878 | $338K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 68% | 22,949 | 18,912 | $1.93M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.6% | 2,242 | 1,915 | $161K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.7% | 1,783 | 1,686 | $134K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.5% | 1,325 | 1,277 | $100K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.3% | 7,148 | 6,446 | $93K |
| 92552 | 3.1% | 3,297 | 3,159 | $87K | |
| 87428 | 2.3% | 2,094 | 1,920 | $65K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 921 | 797 | $50K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 480 | 456 | $39K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 873 | 807 | $26K |
| 90677 | <1% | 137 | 125 | $22K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,424 | 1,337 | $19K |
35 more codes
| 90670 | <1% | 1,015 | $17K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 11,764 | $13K |
| 90686 | <1% | 1,108 | $13K | |
| 90648 | <1% | 1,120 | $12K | |
| 90723 | <1% | 628 | $10K | |
| 87807 | <1% | 653 | $8K | |
| 99173 | <1% | 3,226 | $8K | |
| 81003 | <1% | 3,211 | $7K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 102 | $6K |
| 90461 | <1% | 3,031 | $4K | |
| 99188 | <1% | 181 | $3K | |
| 90633 | <1% | 215 | $3K | |
| 90716 | <1% | 177 | $3K | |
| 90619 | <1% | 34 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 906 | $2K |
| 90707 | <1% | 151 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 24 | $2K |
| 90681 | <1% | 89 | $2K | |
| 99460 | <1% | 15 | $1K | |
| 90651 | <1% | 59 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 13 | $935.34 |
| 0001A | <1% | 13 | $538.00 | |
| 90696 | <1% | 42 | $490.68 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 43 | $481.08 |
| 85018 | <1% | 168 | $383.76 | |
| 90734 | <1% | 20 | $323.01 | |
| 90710 | <1% | 27 | $286.00 | |
| 92015 | Determination of refractive state | <1% | 139 | $256.88 |
| 81002 | <1% | 72 | $189.09 | |
| 90657 | <1% | 14 | $162.51 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $116.08 |
| D1206 | Topical application of fluoride varnish | <1% | 19 | $41.58 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 40 | $33.67 |
| 91300 | <1% | 39 | $0.33 | |
| 91307 | <1% | 23 | $0.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANEY, MATTHEW (PEDIATRICIAN/OWNER)